Cargando…
Establishing a yeast-based screening system for discovery of human GLUT5 inhibitors and activators
Human GLUT5 is a fructose-specific transporter in the glucose transporter family (GLUT, SLC2 gene family). Its substrate-specificity and tissue-specific expression make it a promising target for treatment of diabetes, metabolic syndrome and cancer, but few GLUT5 inhibitors are known. To identify and...
Autores principales: | Tripp, Joanna, Essl, Christine, Iancu, Cristina V., Boles, Eckhard, Choe, Jun-yong, Oreb, Mislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524692/ https://www.ncbi.nlm.nih.gov/pubmed/28740135 http://dx.doi.org/10.1038/s41598-017-06262-4 |
Ejemplares similares
-
Functional Expression of the Human Glucose Transporters GLUT2 and GLUT3 in Yeast Offers Novel Screening Systems for GLUT-Targeting Drugs
por: Schmidl, Sina, et al.
Publicado: (2021) -
GLUT3 inhibitor discovery through in silico ligand screening and in vivo validation in eukaryotic expression systems
por: Iancu, Cristina V., et al.
Publicado: (2022) -
Identification of new GLUT2-selective inhibitors through in silico ligand screening and validation in eukaryotic expression systems
por: Schmidl, Sina, et al.
Publicado: (2021) -
Ligand Screening Systems for Human Glucose Transporters as Tools in Drug Discovery
por: Schmidl, Sina, et al.
Publicado: (2018) -
Novel strategies to improve co-fermentation of pentoses with D-glucose by recombinant yeast strains in lignocellulosic hydrolysates
por: Oreb, Mislav, et al.
Publicado: (2012)